RxDoctor Payments Data

Leah Craft, MD

Family Medicine · South Bend, INNPI 1467687277

Payments from drug & device makers

$294in general payments, 2019–2025

Across 18 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$79
  • Novartis$54
  • GSK$32
  • Johnson & Johnson$25
  • Sunovion Pharmaceuticals Inc.$17
  • Novo Nordisk$15
  • plus $72 from 5 others

What the payments were for

  • Food & beverage$294100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$294 in reported general payments places this provider in the 40th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$81,533
Medicare patients
264
Services billed
1,175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide91$133,976
Trelegy ElliptaFluticasone/Umeclidin/Vilanter90$127,365
JanuviaSitagliptin Phosphate69$76,896
EliquisApixaban66$60,429
XareltoRivaroxaban39$54,341
JardianceEmpagliflozin35$45,964
Spiriva RespimatTiotropium Bromide40$45,402
TrulicityDulaglutide34$44,905
MounjaroTirzepatide19$32,265
Lantus SolostarInsulin Glargine,hum.Rec.Anlog98$24,367
LinzessLinaclotide22$22,400
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog36$19,847
Combivent RespimatIpratropium/Albuterol Sulfate12$12,064
Tresiba Flextouch U-100Insulin Degludec15$10,336
Dexlansoprazole DrDexlansoprazole23$6,803

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$133,97691 claims
GSKTrelegy Ellipta$32$127,36590 claims
Johnson & JohnsonXarelto$25$54,34139 claims
AbbVieLinzess, Synthroid$79$23,67150 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in South Bend

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →